ARCHIVES

DCT Board Ok’s concept For In Vivo Combination Studies

This article is from The Cancer Letter archive.

Vol. 16 No. 45 | November 23, 1990

Download PDF Visit The Full Archive

Related Articles

Health Organizations: ACS Advises annual Prostate Screening for some Younger Men

June 20, 1997

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.

July 28, 2000